NCT02250833

CKD-828 (80/5mg) Pharmacokinetic Study

To Compare the Pharmacokinetics and Safety of CKD-828 80/5mg to Coadministration of Telmisartan 80mg and S-amlodipine 5mg in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 69 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: Male
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

A randomized, open-label, single-dose, two-period, two-way, crossover study to compare the pharmacokinetics and safety CKD-828 (Fixed Dose Combination Tablet) to coadministration telmisartan and s-amlodipine in health volunteers.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	CKD-828	Telmisartan 80mg /S-Amlodipine 5mg(FDC) Tablet, Oral, Once Daily
DRUG	Telmisartan	\- Telmisartan 80mg tablet, Oral, Once Daily (Combination Therapy with S-amlodipine)
DRUG	S-amlodipine	\- S-amlodipine 5mg tablet, Oral, Once Daily (combination Therapy with Telmisartan)

Timeline

• Start date: 2014-09-01
• Primary completion: 2014-12-01
• Completion: 2014-12-01
• First posted: 2014-09-26
• Last updated: 2015-04-10

Locations

1 site across 1 country: South Korea